XHR6XGAReplacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10
- Billable / Specific Code
XHR6XGA is a billable ICD-10-PCS procedure code for Replacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 018. The root operation Replacement involves putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Skin graft.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | H | Skin, Subcutaneous Tissue, Fascia and Breast |
| 3 | Operation | R | Replacement |
| 4 | BodyPart | 6 | Skin, Right Lower Extremity |
| 5 | Approach | X | External |
| 6 | Device/Substance/Technology | G | Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy |
| 7 | Qualifier | A | New Technology Group 10 |
Clinical Classification (CCSR)
AHRQ groups XHR6XGA into these clinical categories.
Code History
Similar Procedure Codes
Questions About XHR6XGA
Is XHR6XGA a billable code?
Yes. XHR6XGA is a complete seven-character ICD-10-PCS code, specific enough to report Replacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XHR6XGA mean?
XHR6XGA breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character H is the Body System (Skin, Subcutaneous Tissue, Fascia and Breast); the 3rd character R is the Operation (Replacement); the 4th character 6 is the BodyPart (Skin, Right Lower Extremity); the 5th character X is the Approach (External); the 6th character G is the Device/Substance/Technology (Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy); the 7th character A is the Qualifier (New Technology Group 10).
What MS-DRG does XHR6XGA group to?
On an inpatient stay, Replacement of Right Lower Extremity Skin with Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy, External Approach, New Technology Group 10 maps to MS-DRG 018 (chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies). The MS-DRG sets the fixed Medicare payment for the stay.
